Search - Université de Rennes Access content directly

Filter your results

23 Results
Author: personID (integer) : 757059
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1

Epidemiological, clinical, biological and virological factors influencing the occurrence of hepatocellular carcinoma and validation of predictive scores in 317 HBV-related cirrhotic patients. Prospective study Cir-B nested in the ANRS CO12 CirVir cohort

Sepolene Brichler , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Hepatology, 2016, 63 (1 SUPP), pp.898A--899A
Journal articles hal-01414692v1

Impact of the New MELD-based Allocation System on Waiting List and Post-Transplant Survival - A Cohort Analysis Using the French National CRISTAL Database

Carine Jasseron , Claire Francoz , Corinne Antoine , Camille Legeai , François Durand et al.
Transplant International, 2019, 32 (10), pp.1061--1073. ⟨10.1111/tri.13448⟩
Journal articles hal-02862291v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-02648451v1

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (5), pp.1436-1450.e6. ⟨10.1053/j.gastro.2018.07.015⟩
Journal articles hal-02648450v1

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

Jean-Claude Trinchet , Valérie Bourcier , Cendrine Chaffaut , Mohand Ait Ahmed , Setty Allam et al.
Hepatology, 2015, 62 (3), pp.737-750. ⟨10.1002/hep.27743⟩
Journal articles hal-01201948v1
Image document

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

Manon Allaire , Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot et al.
Hepatology, 2018, 68 (4), pp.1245-1259. ⟨10.1002/hep.30034⟩
Journal articles hal-02648452v1

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1

Sofosbuvir plus Velpatasvir plus Voxilaprevir in Daa Failure Patients with Cirrhosis. Final Results of the French Compassionate Use Program

Christophe Hezode , Dominique Guyader , Eric Nguyen-Khac , Dominique Larrey , Regine Truchi et al.
Hepatology, 2018, 68 (1), pp.374A
Journal articles hal-03590862v1

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

Isabelle Ollivier-Hourmand , Yohann Repesse , Pierre Nahon , Cendrine Chaffaut , Thông Dao et al.
Liver International, 2022, 42 (6), pp.1386-1400. ⟨10.1111/liv.15159⟩
Journal articles hal-03553907v1
Image document

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Christophe Hézode , Hélène Fontaine , Céline Dorival , Fabien Zoulim , Dominique Larrey et al.
Gastroenterology, 2014, 147 (1), pp.132-142.e4. ⟨10.1053/j.gastro.2014.03.051⟩
Journal articles inserm-01057763v1

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

Pierre Nahon , Mathilde Lescat , Richard Layese , Valérie Bourcier , Nabila Talmat et al.
Gut, 2017, 66 (2), pp.330-341. ⟨10.1136/gutjnl-2015-310275⟩
Journal articles hal-01225507v1

Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program

Christophe Hezode , Dominique Guyader , Eric Nguyen-Khac , Dominique Larrey , Regine Truchi et al.
Journal of Hepatology, 2019, 70 (1, 1), pp.E224. ⟨10.1016/S0618-8278(19)30417-7⟩
Journal articles hal-03590860v1

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

Christophe Hézode , Victor De Ledinghen , Hélène Fontaine , Fabien Zoulim , Pascal Lebray et al.
Hepatology, 2015, 62, pp.314A--314A. ⟨10.1002/hep.28160⟩
Journal articles hal-01380169v1

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode , Hélène Fontaine , Céline Dorival , Dominique Larrey , Fabien Zoulim et al.
Journal of Hepatology, 2013, 59 (3), pp.434 - 441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal articles hal-01708037v1

Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy

Michel Rosenheim , Jean-François Cadranel , Lieven Stuyver , Richard Dorent , Franck Golliot et al.
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2006, 30 (11), pp.1274-80. ⟨10.1016/s0399-8320(06)73535-7⟩
Journal articles hal-00465327v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-04075104v1

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon , Valérie Bourcier , Richard Layese , Etienne Audureau , Carole Cagnot et al.
Gastroenterology, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Journal articles hal-01447065v1
Image document

Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status

Etienne Audureau , Fabrice Carrat , Richard Layese , Carole Cagnot , Tarik Asselah et al.
Journal of Hepatology, 2020, 73 (6), pp.1434-1445. ⟨10.1016/j.jhep.2020.05.052⟩
Journal articles hal-03284519v1